[ad_1] Resources prioritized to advance avexitide in hyperinsulinemic hypoglycemia indications Phase 3 LIMT-2 study of peginterferon lambda in chronic hepatitis delta discontinued due to safety findings Company’s cash runway expected…
Tag: Biopharmaceuticals
Elevate Your Leadership Skills in Pharma: Agile Leadership Training for Professionals (March 7-8, 2024)
[ad_1] Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) — The “Agile Leadership for Pharma and Biopharma Professionals in a hybrid world Training Course” conference has been added to ResearchAndMarkets.com’s offering. Working…
Roche to Buy Bowel-Disease Drug From Roivant, Pfizer for More Than $7 Billion
[ad_1] Updated Oct. 23, 2023 6:55 am ET Roche Holding has agreed to buy the developer of a bowel-disease treatment from Roivant Sciences, a company started by Republican presidential candidate…
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 Billion
[ad_1] The deal expands the pharmaceutical company’s portfolio of cancer drugs. [ad_2] Source link
WSJ News Exclusive | The Hedge Fund That Made a Killing Betting Against Lina Khan
[ad_1] Pentwater Capital predicted that FTC efforts to block big deals would fail. [ad_2] Source link
Blockbuster Cancer Treatment Stymied by Supply Chain—for Now
[ad_1] A cell therapy for multiple myeloma promises to be a major blockbuster for J&J and partner Legend, if they can increase manufacturing. [ad_2] Source link